Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 29-Dec-21 4:21 PM View:  | Smith Cynthia Director | Dicerna Pharmaceuticals Inc (DRNA) | 28-Dec-21 | Disposition (change in control) | 3,333 | $38.25 | $127,487.00 | (100%) 3.33K to 0 | < 1% |
| 29-Dec-21 4:22 PM View: | Weissman James B Chief Operating Officer & EVP | Dicerna Pharmaceuticals Inc (DRNA) | 28-Dec-21 | Disposition (change in control) | 18,100 | $38.25 | $692,325.00 | (100%) 18.1K to 0 | < 1% |
| 29-Dec-21 4:21 PM View: | Kozin Marc D Director | Dicerna Pharmaceuticals Inc (DRNA) | 28-Dec-21 | Disposition | 6,333 | $38.25 | $242,237.00 | (56%) 11.33K to 5.0K | < 1% |
| 29-Dec-21 4:17 PM View: | Aradhye Shreeram EVP & Chief Medical Officer | Dicerna Pharmaceuticals Inc (DRNA) | 28-Dec-21 | Disposition (change in control) | 6,973 | $38.25 | $266,717.00 | (100%) 6.97K to 0 | < 1% |
| 29-Dec-21 4:20 PM View: | Freed Martin I Director | Dicerna Pharmaceuticals Inc (DRNA) | 28-Dec-21 | Disposition (change in control) | 3,333 | $38.25 | $127,487.00 | (100%) 3.33K to 0 | < 1% |
| 29-Dec-21 4:20 PM View: | Gray Patrick M. Director | Dicerna Pharmaceuticals Inc (DRNA) | 28-Dec-21 | Disposition (change in control) | 3,333 | $38.25 | $127,487.00 | (100%) 3.33K to 0 | < 1% |
| 29-Dec-21 4:19 PM View: | Fambrough Douglas Chief Executive Officer Director | Dicerna Pharmaceuticals Inc (DRNA) | 28-Dec-21 | Disposition | 231,431 | $38.25 | $8,852,240.00 | (100%) 231.43K to 0 | < 1% |
| 29-Dec-21 4:20 PM View: | Hoffman Stephen J Director | Dicerna Pharmaceuticals Inc (DRNA) | 28-Dec-21 | Disposition (change in control) | 16,157 | $38.25 | $618,005.00 | (100%) 16.16K to 0 | < 1% |
| 29-Dec-21 4:21 PM View: | Pagan Douglas W. Chief Financial Officer | Dicerna Pharmaceuticals Inc (DRNA) | 28-Dec-21 | Disposition (change in control) | 7,775 | $38.25 | $297,394.00 | (100%) 7.78K to 0 | < 1% |
| 29-Dec-21 4:21 PM View: | Kozin Marc D Director | Dicerna Pharmaceuticals Inc (DRNA) | 28-Dec-21 | Disposition | 5,000 | $38.25 | $191,250.00 | (100%) 5.0K to 0 | < 1% |
| 29-Dec-21 4:43 PM View: | Koppel Adam Director | Dicerna Pharmaceuticals Inc (DRNA) | 28-Dec-21 | Disposition (change in control) | 3,333 | $38.25 | $127,487.00 | (< 1%) 3.08M to 3.08M | < 1% |
| 29-Dec-21 4:18 PM View: | Buchi J Kevin Director | Dicerna Pharmaceuticals Inc (DRNA) | 28-Dec-21 | Disposition (change in control) | 4,666 | $38.25 | $178,474.00 | (100%) 4.67K to 0 | < 1% |
| 29-Dec-21 4:19 PM View: | Ciappenelli Robert D. Chief Strategy Officer | Dicerna Pharmaceuticals Inc (DRNA) | 28-Dec-21 | Disposition (change in control) | 14,813 | $38.25 | $566,597.00 | (100%) 14.81K to 0 | < 1% |
| 29-Dec-21 4:22 PM View: | Zeng Ling Chief Legal Officer & Sec'y | Dicerna Pharmaceuticals Inc (DRNA) | 28-Dec-21 | Disposition (change in control) | 5,032 | $38.25 | $192,474.00 | (100%) 5.03K to 0 | < 1% |
| 29-Dec-21 4:43 PM View: | Koppel Adam Director | Dicerna Pharmaceuticals Inc (DRNA) | 28-Dec-21 | Disposition (change in control) | 3,080,240 | $38.25 | $117,819,000.00 | (100%) 3.08M to 0 | < 1% |
| 29-Dec-21 4:19 PM View: | Doberstein Stephen K Director | Dicerna Pharmaceuticals Inc (DRNA) | 28-Dec-21 | Disposition (change in control) | 3,333 | $38.25 | $127,487.00 | (100%) 3.33K to 0 | < 1% |
| 29-Dec-21 4:18 PM View: | Brown Bob Chief Scientific Ofr., EVP R&D | Dicerna Pharmaceuticals Inc (DRNA) | 28-Dec-21 | Disposition (change in control) | 2,367 | $38.25 | $90,537.80 | (100%) 2.37K to 0 | < 1% |
| 17-Dec-21 4:18 PM View: | Pagan Douglas W. Chief Financial Officer | Dicerna Pharmaceuticals Inc (DRNA) | 15-Dec-21 | Option Exercise | 2,050 | -- | -- | 32% 6.33K to 8.38K | |
| 17-Dec-21 4:16 PM View: | Zeng Ling Chief Legal Officer & Sec'y | Dicerna Pharmaceuticals Inc (DRNA) | 15-Dec-21 | Option Exercise | 2,562 | -- | -- | 80% 3.22K to 5.78K | |
| 17-Dec-21 4:18 PM View: | Pagan Douglas W. Chief Financial Officer | Dicerna Pharmaceuticals Inc (DRNA) | 15-Dec-21 | Payment of Exercise | 602 | $38.05 | $22,906.10 | (7%) 8.38K to 7.78K | < 1% |
| 17-Dec-21 4:16 PM View: | Brown Bob Chief Scientific Ofr., EVP R&D | Dicerna Pharmaceuticals Inc (DRNA) | 15-Dec-21 | Payment of Exercise | 1,675 | $38.05 | $63,733.80 | (41%) 4.04K to 2.37K | < 1% |
| 17-Dec-21 4:16 PM View: | Fambrough Douglas Chief Executive Officer Director | Dicerna Pharmaceuticals Inc (DRNA) | 15-Dec-21 | Option Exercise | 13,750 | -- | -- | 6% 223.03K to 236.78K | |
| 17-Dec-21 4:18 PM View: | Ciappenelli Robert D. Chief Strategy Officer | Dicerna Pharmaceuticals Inc (DRNA) | 15-Dec-21 | Option Exercise | 3,425 | -- | -- | 27% 12.63K to 16.05K | |
| 17-Dec-21 4:17 PM View: | Aradhye Shreeram EVP & Chief Medical Officer | Dicerna Pharmaceuticals Inc (DRNA) | 15-Dec-21 | Option Exercise | 2,837 | -- | -- | 57% 4.97K to 7.81K | |
| 17-Dec-21 4:16 PM View: | Zeng Ling Chief Legal Officer & Sec'y | Dicerna Pharmaceuticals Inc (DRNA) | 15-Dec-21 | Payment of Exercise | 752 | $38.05 | $28,613.60 | (13%) 5.78K to 5.03K | < 1% |
| 17-Dec-21 4:17 PM View: | Weissman James B Chief Operating Officer & EVP | Dicerna Pharmaceuticals Inc (DRNA) | 15-Dec-21 | Payment of Exercise | 1,675 | $38.05 | $63,733.80 | (8%) 19.77K to 18.1K | < 1% |
| 17-Dec-21 4:16 PM View: | Fambrough Douglas Chief Executive Officer Director | Dicerna Pharmaceuticals Inc (DRNA) | 15-Dec-21 | Payment of Exercise | 5,348 | $38.05 | $203,491.00 | (2%) 236.78K to 231.43K | < 1% |
| 17-Dec-21 4:18 PM View: | Ciappenelli Robert D. Chief Strategy Officer | Dicerna Pharmaceuticals Inc (DRNA) | 15-Dec-21 | Payment of Exercise | 1,241 | $38.05 | $47,220.10 | (8%) 16.05K to 14.81K | < 1% |
| 17-Dec-21 4:17 PM View: | Aradhye Shreeram EVP & Chief Medical Officer | Dicerna Pharmaceuticals Inc (DRNA) | 15-Dec-21 | Payment of Exercise | 833 | $38.05 | $31,695.60 | (11%) 7.81K to 6.97K | < 1% |
| 17-Dec-21 4:16 PM View: | Brown Bob Chief Scientific Ofr., EVP R&D | Dicerna Pharmaceuticals Inc (DRNA) | 15-Dec-21 | Option Exercise | 3,775 | -- | -- | 1414% 0.27K to 4.04K | |
| 17-Dec-21 4:17 PM View: | Weissman James B Chief Operating Officer & EVP | Dicerna Pharmaceuticals Inc (DRNA) | 15-Dec-21 | Option Exercise | 3,775 | -- | -- | 24% 16.0K to 19.77K | |
| 14-Dec-21 9:02 PM View: | Ciappenelli Robert D. Chief Strategy Officer | Dicerna Pharmaceuticals Inc (DRNA) | 13-Dec-21 | Option Exercise | 8,856 | $22.58 | $199,968.00 | 235% 3.77K to 12.63K | |
| 13-Dec-21 7:33 PM View: | Fambrough Douglas Chief Executive Officer Director | Dicerna Pharmaceuticals Inc (DRNA) | 10-Dec-21 | Option Exercise | 179,865 | $3.34 | $599,987.00 | 417% 43.16K to 223.03K | |
| 22-Nov-21 4:38 PM View: | Brown Bob Chief Scientific Ofr., EVP R&D | Dicerna Pharmaceuticals Inc (DRNA) | 18-Nov-21 | Option Exercise | 24,936 | $3.42 | $85,281.10 | 9339% 0.27K to 25.2K | |
| 22-Nov-21 4:38 PM View: | Brown Bob Chief Scientific Ofr., EVP R&D | Dicerna Pharmaceuticals Inc (DRNA) | 18-Nov-21 | Market Option Sale (Planned) | 24,936 | $37.94 | $946,072.00 | (99%) 25.2K to 0.27K | (< 1%) |
| 21-Sep-21 10:00 PM View: | Brown Bob Chief Scientific Ofr., EVP R&D | Dicerna Pharmaceuticals Inc (DRNA) | 17-Sep-21 | Market Sale (Planned) | 21,250 | $21.06 | $447,517.00 | (99%) 21.52K to 0.27K | (80%) |
| 17-Sep-21 6:48 PM View: | Zeng Ling Chief Legal Officer & Sec'y | Dicerna Pharmaceuticals Inc (DRNA) | 17-Sep-21 | Market Option Sale | 1,334 | $21.47 | $28,641.00 | (29%) 4.56K to 3.22K | (77%) |
| 17-Sep-21 6:48 PM View: | Aradhye Shreeram EVP & Chief Medical Officer | Dicerna Pharmaceuticals Inc (DRNA) | 17-Sep-21 | Market Option Sale | 2,056 | $21.47 | $44,142.30 | (29%) 7.03K to 4.97K | (77%) |
| 17-Sep-21 6:48 PM View: | Aradhye Shreeram EVP & Chief Medical Officer | Dicerna Pharmaceuticals Inc (DRNA) | 15-Sep-21 | Option Exercise | 7,025 | -- | -- | 100% 0 to 7.03K | |
| 17-Sep-21 6:48 PM View: | Zeng Ling Chief Legal Officer & Sec'y | Dicerna Pharmaceuticals Inc (DRNA) | 15-Sep-21 | Option Exercise | 4,556 | -- | -- | 100% 0 to 4.56K | |
| 10-Aug-21 6:44 PM View: | Kozin Marc D Director | Dicerna Pharmaceuticals Inc (DRNA) | 10-Aug-21 | Market Purchase | 3,000 | $23.66 | $70,986.00 | 36% 8.33K to 11.33K | 61% |
| 10-Aug-21 8:06 PM View: | Fambrough Douglas President and CEO Director | Dicerna Pharmaceuticals Inc (DRNA) | 10-Aug-21 | Market Purchase | 5,000 | $22.10 | $110,480.00 | 13% 38.16K to 43.16K | 72% |
| 08-Jul-21 9:32 PM View: | Paglia Regina M. Chief Human Resources Officer | Dicerna Pharmaceuticals Inc (DRNA) | 06-Jul-21 | Option Exercise | 3,162 | -- | -- | 1175% 0.27K to 3.43K | |
| 08-Jul-21 9:32 PM View: | Paglia Regina M. Chief Human Resources Officer | Dicerna Pharmaceuticals Inc (DRNA) | 06-Jul-21 | Payment of Exercise | 1,404 | $37.05 | $52,018.20 | (41%) 3.43K to 2.03K | (3%) |
| 08-Jul-21 8:17 PM View: | Weissman James B Chief Operating Officer & EVP | Dicerna Pharmaceuticals Inc (DRNA) | 06-Jul-21 | Option Exercise | 30,000 | $9.09 | $272,700.00 | 188% 16.0K to 46.0K | |
| 08-Jul-21 8:17 PM View: | Weissman James B Chief Operating Officer & EVP | Dicerna Pharmaceuticals Inc (DRNA) | 06-Jul-21 | Market Option Sale (Planned) | 30,000 | $39.09 | $1,172,700.00 | (65%) 46.0K to 16.0K | 3% |
| 06-Jul-21 4:18 PM View: | Brown Bob Chief Scientific Ofr., EVP R&D | Dicerna Pharmaceuticals Inc (DRNA) | 01-Jul-21 | Option Exercise | 8,312 | $3.42 | $28,427.00 | 39% 21.52K to 29.83K | |
| 06-Jul-21 4:18 PM View: | Brown Bob Chief Scientific Ofr., EVP R&D | Dicerna Pharmaceuticals Inc (DRNA) | 01-Jul-21 | Market Option Sale (Planned) | 8,312 | $37.37 | $310,641.00 | (28%) 29.83K to 21.52K | (2%) |
| 29-Jun-21 4:17 PM View: | Paglia Regina M. Chief Human Resources Officer | Dicerna Pharmaceuticals Inc (DRNA) | 25-Jun-21 | Market Option Sale | 1,000 | $38.00 | $38,003.70 | (79%) 1.27K to 0.27K | < 1% |
| 29-Jun-21 4:17 PM View: | Paglia Regina M. Chief Human Resources Officer | Dicerna Pharmaceuticals Inc (DRNA) | 25-Jun-21 | Option Exercise | 1,000 | $22.58 | $22,580.00 | 372% 0.27K to 1.27K |
